Theravance, Inc.

At Theravance Biopharma, Inc., we are working to transform the treatment of serious diseases through the discovery and development of organ-selective medicines designed to maximize patient benefit while minimizing patient risk. As a spin-off of Theravance, Inc., Theravance Biopharma, Inc. was founded in 2014 and has offices in South San Francisco, and Dublin, Ireland. Our R&D and commercialization strategy is in the areas of inflammation and immunology and our pipeline of internally discovered programs is targeted to address significant patient needs. We are a place for collaborators and creative problem-solvers – people who thrive on applying insight and innovation to discovering novel medicines.